|
Remember to add us to your contacts list to ensure you receive our emails
|
|
|
|
|
|
|
|
|
|
|
_________________________________________________________
|
|
Dear Shulyak Alexandr,
Welcome to this edition of EMJ Hematology, which brings you unrelenting coverage of this year’s premiere European haematological event: the 20th European Hematology Association (EHA) Congress, which took place in Vienna, Austria on 11th-14th June. Following a thrilling and momentous four days, our team returned home in great spirits, having witnessed an abundance of new findings, discussions, and debates that covered a mass of haematological subjects during the anniversary congress. Inside we have compiled a series of abstract reviews, highlights of presentations, interviews with key members of the haematological community, and in-depth symposium reviews straight from the congress floor, which will enable our readers to discover many of the vital recent developments from this field of medicine.
|
|
|
|
New treatment options were a key theme of EHA 2015 and great strides have taken place, demonstrated in a series of presentations for conditions such as acute lymphoblastic leukaemia, myelofibrosis, chronic myeloid leukaemia, and multiple myeloma. Inside we have included a series of intriguing articles, discussing areas such as relapsed/refractory multiple myeloma, thrombosis in haematological disorders, mantle cell lymphoma, and the potential of biosimilars to improve patient access in haematology. Our congress review features details of the event’s most exciting presentations. These include an Australian study which provides evidence that a combination of two targeted therapies, venetoclax and rituximab, is a safe and effective therapy for chronic lymphocytic leukaemia, as well as research suggesting that pacritinib, an oral next-generation multikinase inhibitor, significantly improves the disease symptoms and quality of life of myelofibrosis patients.
What's included in this edition of EMJ Hematology?
Editorial Board
Congress Review
Review of the 20th Congress of the European Hematology Association held in Vienna, Austria, 11th-14th June 2015
Interviews with EMJ Hematology Editorial Board and Authors
Symposium Reviews
Abstract Reviews
Article
|
|
Get Involved
Previously this year we published EMJ Oncology, available on our website, which included top-quality manuscripts covering hot topics in oncology and haematology. We hope that this edition of EMJ Hematology will prove to be an enlightening read for our audience, and we are greatly looking forward to the European Cancer Congress (ECC) on 25th-29th September, which will provide further updates in haematology. If you would like to take part in our online discussion forum, please feel free to take advantage of our social media channels including Facebook, LinkedIn, and YouTube.
Warm regards,
Zoë Webster
Head of Publishing
|
|
|
|
|
_________________________________________________________
|
|
|
European Medical Journal
Head Office – The MedBIC, Anglia Ruskin University, Alan Cherry Drive, Chelmsford, Essex, CM1 1SQ
Sales Office - Coppergate House, 16 Brune Street, London, E1 7NJ
Switchboard: +44 (0) 1245 334450
Visit Website
Registration No: 08198092. The information contained in this message is confidential and maybe legally privileged. It is intended for the addressee(s) only. Any unauthorised use, dissemination of the information, or unauthorised copying/forwarding of this message is prohibited. If you are not the intended addressee, please notify the sender immediately by return email and delete this message. Any views expressed in this message are those of the individual sender, except where the message states otherwise and the sender is authorised to state them.
|
|
|
_________________________________________________________
|
|
|
|
|
To ensure that you continue receiving our emails, please add us to your address book or safe list. If you are receiving this email continuously and if you think this is SPAM, please report to circulation@emjreviews.com and we will try our best to resolve your concerns. If you would like to Subscribe, please follow the link at the bottom through to our automated system, alternatively if you would like to Unsubscribe please also use the link provided.
|
|
|
|
|
|
|
.jpg)
_newsletter.jpg)
_newsletter.jpg)
